首頁 > 市場調查報告書 > 醫療設備

呼吸器

市場調查報告書

商品編碼

2055359

人工肺市場：依產品類型、患者類型、最終用戶和地區分類

Artificial Lung Market, By Product Type, By Patient Type, By End User, By Geography

出版日期: 2026年03月11日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，人工肺市場規模將達到23.2億美元，到2033年將達到46億美元。預計從2026年到2033年，其複合年成長率將達到10.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	23.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.30%	2033年市場規模預測：	46億美元

全球人工肺市場在整個醫療設備業中佔據重要佔有率，專注於先進的生命維持技術，旨在暫時或永久地取代患有嚴重呼吸系統疾病的患者的自然肺功能。

人工肺，也稱為體外膜氧合（ECMO）系統或機械肺支持裝置，是治療急性呼吸窘迫症候群（ARDS）、慢性阻塞性肺病（COPD）、肺動脈栓塞和其他危及生命的呼吸衰竭患者的重要治療方案。這些先進的醫療設備透過向血液輸送氧氣並將二氧化碳排出體外來發揮作用，有效地取代了健康肺部通常執行的氣體交換功能。

該市場涵蓋多種技術方案，包括膜式氧合器、人工肺植入和穿戴式式人工肺系統，每種方案都旨在滿足特定的患者需求和臨床場景。呼吸系統疾病在全球範圍內日益普遍、人口老化以及近期呼吸系統流行病的影響，引起了醫療專業人員、醫療設備製造商和投資者的高度關注，他們都在尋求創新解決方案，以應對重症監護環境中的緊急醫療挑戰並改善患者預後。

市場動態

全球人工肺市場的主要驅動力是全球呼吸系統疾病（包括慢性阻塞性肺病)、急性呼吸窘迫症候群 ( ARDS) 和肺纖維化）盛行率的不斷上升。這些疾病影響著全球數百萬患者，從而產生了對先進呼吸支援技術的巨大需求。全球人口老化也是市場成長的重要因素。老年人更容易出現呼吸系統併發症，且往往需要重症監護，而生物相容性材料、小型化和氣體交換效率的提高等技術進步正在提升人工肺系統的性能和安全性。

新冠疫情凸顯了呼吸支援設備的緊迫性，並促使全球醫療基礎設施投資增加，尤其加速了市場擴張。然而，市場成長受到許多因素的限制，包括人工肺設備及其維護成本極高、複雜的監管核准流程可能導致產品上市延遲，以及這些侵入性操作帶來的出血、感染疾病和血栓症等併發症的重大風險。此外，熟練操作先進人工肺系統的醫護人員短缺，以及發展中國家難以取得這些設備，進一步限制了市場滲透。儘管如此，生物工程領域仍蘊藏著巨大的機遇，尤其是在可植入式人工肺和穿戴式裝置的研發方面，這些裝置有望徹底改變患者照護模式。

將人工智慧 (AI) 和機器學習技術應用於預測性監測和自動調節，為市場擴張提供了一條充滿希望的途徑。同時，新興市場醫療保健支出不斷成長，以及人們對先進呼吸照護解決方案的認知度日益提高，也創造了新的成長機會。醫療設備製造商與醫療機構之間的策略合作，以及政府支持急救醫療基礎設施建設的各項舉措，預計將推動人工肺領域的市場持續成長和創新。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數創建了全球人工肺市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球人工肺市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
透過各種用於分析全球人工肺市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

Medtronic plc
Getinge AB
LivaNova PLC
Terumo Corporation
Fresenius Medical Care AG & Co. KGaA
ALung Technologies, Inc.
Breethe, Inc.
Miromatrix Medical Inc.
Abiomed, Inc.
Cyanagen Srl
Nipro Corporation
Hemovent GmbH

第12章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8255

Artificial Lung Market is estimated to be valued at USD 2.32 Bn in 2026 and is expected to reach USD 4.60 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.32 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.30%	2033 Value Projection:	USD 4.60 Bn

The global artificial lung market represents a critical segment within the broader medical device industry, focusing on advanced life-support technologies designed to temporarily or permanently replace natural lung function in patients with severe respiratory conditions.

Artificial lungs, also known as extracorporeal membrane oxygenation (ECMO) systems or mechanical lung support devices, serve as vital therapeutic solutions for patients suffering from acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pulmonary embolism, and other life-threatening respiratory failures. These sophisticated biomedical devices function by oxygenating blood and removing carbon dioxide outside the body, effectively performing the gas exchange function typically handled by healthy lungs.

The market encompasses various technological approaches, including membrane oxygenators, artificial lung implants, and wearable artificial lung systems, each designed to address specific patient needs and clinical scenarios. With the increasing prevalence of respiratory diseases globally, aging populations, and the recent impact of respiratory pandemics, the artificial lung market has gained significant attention from healthcare providers, medical device manufacturers, and investors seeking innovative solutions to address critical care challenges and improve patient outcomes in intensive care settings.

Market Dynamics

The global artificial lung market is primarily driven by the escalating prevalence of respiratory diseases worldwide, including chronic obstructive pulmonary disease, acute respiratory distress syndrome, and pulmonary fibrosis, which collectively affect millions of patients globally and create substantial demand for advanced respiratory support technologies. The aging global population significantly contributes to market growth, as elderly individuals are more susceptible to respiratory complications and require intensive care interventions, while technological advancements in biocompatible materials, miniaturization, and improved gas exchange efficiency have enhanced the performance and safety profiles of artificial lung systems.

The COVID-19 pandemic has particularly accelerated market expansion by highlighting the critical need for respiratory support devices and increasing healthcare infrastructure investments globally. However, market growth faces considerable restraints, including the extremely high costs associated with artificial lung devices and their maintenance, complex regulatory approval processes that can delay product launches, and the significant risk of complications such as bleeding, infection, and thrombosis associated with these invasive procedures. The shortage of skilled healthcare professionals trained in operating sophisticated artificial lung systems, coupled with limited availability of these devices in developing regions, further constrains market penetration. Nevertheless, substantial opportunities exist through ongoing research and development in bioengineering, particularly in developing implantable artificial lungs and wearable devices that could revolutionize patient care.

The integration of artificial intelligence and machine learning technologies for predictive monitoring and automated adjustments presents promising avenues for market expansion, while increasing healthcare expenditure in emerging markets and growing awareness about advanced respiratory care solutions create new growth opportunities. Strategic partnerships between medical device manufacturers and healthcare institutions, along with government initiatives supporting critical care infrastructure development, are expected to drive sustained market growth and innovation in the artificial lung sector.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial lung market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, ALung Technologies, Inc., Breethe, Inc., Miromatrix Medical Inc., Abiomed, Inc., Cyanagen Srl, Nipro Corporation, and Hemovent GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global artificial lung market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial lung market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2021 - 2033)
Extracorporeal Membrane Oxygenation (ECMO) Systems
- Veno-Arterial (VA) ECMO
- Veno-Venous (VV) ECMO
Paracorporeal Artificial Lungs
- Pumpless Paracorporeal Devices
- Pump-Assisted Paracorporeal Devices
Implantable Artificial Lungs
- Intrathoracic Devices
- Vascular Graft-Integrated Devices
Others (Oxygenators)
Technology Insights (Revenue, USD Bn, 2021 - 2033)
Perfusion Systems
Membrane Oxygenation Technology
Microfluidic Oxygenators
Biohybrid Systems
Pumpless Gas Exchange Systems
Others (3D-Printed Artificial Lung Constructs, etc.)
Portability Insights (Revenue, USD Bn, 2021 - 2033)
Stationary Systems
Portable Systems
Wearable Systems
Application Insights (Revenue, USD Bn, 2021 - 2033)
Lung Transplant Support (Bridge-to-Transplant)
Acute Respiratory Distress Syndrome (ARDS)
Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
Others (Coronary Artery Bypass Grafting, etc.)
Patient Type Insights (Revenue, USD Bn, 2021 - 2033)
Neonates
Pediatric
Adult
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Transplant Centers
Ambulatory Surgical Centers
Emergency and Trauma Centers
Home Care Settings (for wearable devices)
Others (Research Institutes, etc.)
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Medtronic plc
Getinge AB
LivaNova PLC
Terumo Corporation
Fresenius Medical Care AG & Co. KGaA
ALung Technologies, Inc.
Breethe, Inc.
Miromatrix Medical Inc.
Abiomed, Inc.
Cyanagen Srl
Nipro Corporation
Hemovent GmbH

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Artificial Lung Market, By Product Type
- Global Artificial Lung Market, By Technology
- Global Artificial Lung Market, By Portability
- Global Artificial Lung Market, By Application
- Global Artificial Lung Market, By Patient Type
- Global Artificial Lung Market, By End User
- Global Artificial Lung Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Artificial Lung Market, By Product Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Extracorporeal Membrane Oxygenation (ECMO) Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Veno-Arterial (VA) ECMO
  - Veno-Venous (VV) ECMO
Paracorporeal Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Pumpless Paracorporeal Devices
  - Pump-Assisted Paracorporeal Devices
Implantable Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Intrathoracic Devices
  - Vascular Graft-Integrated Devices
Others (Oxygenators)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Artificial Lung Market, By Technology, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Perfusion Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Membrane Oxygenation Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Microfluidic Oxygenators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Biohybrid Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pumpless Gas Exchange Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others (3D-Printed Artificial Lung Constructs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Artificial Lung Market, By Portability, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Stationary Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Portable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Wearable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Artificial Lung Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Lung Transplant Support (Bridge-to-Transplant)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Acute Respiratory Distress Syndrome (ARDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others (Coronary Artery Bypass Grafting, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Artificial Lung Market, By Patient Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Artificial Lung Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Emergency and Trauma Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Home Care Settings (for wearable devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Artificial Lung Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Portability, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Medical Care AG & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ALung Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Breethe, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Miromatrix Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abiomed, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cyanagen Srl
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hemovent GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies